reversed allowance for doubtful accounts amounting to Baht 8.4 million or equivalent to 80% when compared with same quarter of prior year. Because the Company received the payment of advance for share
%) Tax income (expense) (2.64 ) 0.00 2.64 N/A (3.91%) 0.00% Profit (loss) for the period (23.21 ) (28.30 ) 5.09 17.99% (34.40%) (50.12%) Basic earnings per share-Owners of the Company (0.03 ) (0.03
period (53.94 ) (62.24 ) 8.30 13.34% (44.38%) (56.63%) Basic earnings per share-Owners of the Company (0.06 ) (0.07 ) Attributable to Owners of the Company (53.94) (62.24) 8.30 13.34% Non-controlling
% -2.1% - Basic earnings per share (Baht/share) 0.03 0.06 0.05 0.07 (0.03) (56.8) Net profit margin 3.1% 6.6% 5.8% 7.4% -3.5% - Page 2 of 11 Sales and service income Table 2 : Sales by Product Type for
จากวันที่ 30 กันยายน 2561 ท าให้ มูลค่าทางบัญชีต่อหุ้น (Book Value per Share) ของบริษัทฯ อยู่ที่ 17.91 และมีอัตราส่วนหนี้สินต่อทุน (D/E ratio) ที่ 0.35 เท่า กระแสเงินสด ณ วันที่ 30 กันยายน 2562 บริษัทฯ
60.96 -26.80 -44.0% 112.60 198.28 -85.68 -43.2% Financial expenses -0.94 -1.67 0.73 -43.7% -2.97 -4.30 1.33 -30.9% Share of income from investment in associate 0.45 0.65 -0.20 -30.8% 1.52 1.47 0.05 3.4
10% in sales from 2019 by maintaining our market share in domestic market and improving our sales strategy as well as developing new products and driving to expand in export market. After the Company
% Finance costs 14 17 -17% 66 60 +10% Share of profit (loss) from investment in subsidiaries and joint ventures (8) (0) -5374% (12) (16) +28% Tax (income) (17) (48) +65% (66) (101) +35% Net profit (loss
% from 1Q2019. In 1Q2020, the Company recorded share of profit from investment in Joint Ventures, Thai Ethoxylates Company Limited (TEX) and GGC KTIS Bio Industrial Company Limited (GKBI), at THB 62